# Efficacy and Safety of Different Concentrations of Mapracorat Ointment Over 4 Weeks in Atopic Dermatitis (AD)

> **NCT01359787** · PHASE2 · COMPLETED · sponsor: **Bayer** · enrollment: 197 (actual)

## Conditions studied

- Atopic Dermatitis
- Eczema

## Interventions

- **DRUG:** Mapracorat
- **DRUG:** Vehicle without active

## Key facts

- **NCT ID:** NCT01359787
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 197 (ACTUAL)
- **Last updated:** 2015-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01359787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01359787, "Efficacy and Safety of Different Concentrations of Mapracorat Ointment Over 4 Weeks in Atopic Dermatitis (AD)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01359787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*